AAM Biotechnology Opp 15M CDA 2021-2 CA
Fund
BOPACX
Price as of:
$11.79
+ $0.05
+ 0.43%
Primary Theme
N/A
fund company
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
$11.79
-
0.00%
0.39%
Vitals
YTD Return
N/A
1 yr return
N/A
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$N/A
Holdings in Top 10
38.8%
52 WEEK LOW AND HIGH
$11.7
$9.68
$12.21
Expenses
OPERATING FEES
Expense Ratio 0.39%
SALES FEES
Front Load 0.00%
Deferred Load 1.25%
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Unknown
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
$11.79
-
0.00%
0.39%
BOPACX - Profile
Distributions
- YTD Total Return N/A
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameBiotechnology Opportunities Portfolio - 15 Month, CDA Series 2021-2Q
-
Fund Family NameAdvisors Asset Management, Inc.
-
Inception DateMay 11, 2021
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
Fund Description
BOPACX - Performance
Return Ranking - Trailing
Period | BOPACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -26.9% | 25.3% | N/A |
1 Yr | N/A | -60.2% | 11.7% | N/A |
3 Yr | N/A* | -10.0% | 19.7% | N/A |
5 Yr | N/A* | -6.4% | 16.9% | N/A |
10 Yr | N/A* | 6.4% | 18.5% | N/A |
* Annualized
Return Ranking - Calendar
Period | BOPACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -79.9% | 24.2% | N/A |
2022 | N/A | -13.6% | 178.2% | N/A |
2021 | N/A | 3.8% | 63.8% | N/A |
2020 | N/A | -49.7% | 21.5% | N/A |
2019 | N/A | -59.8% | 54.4% | N/A |
Total Return Ranking - Trailing
Period | BOPACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | N/A | -46.5% | 25.3% | N/A |
1 Yr | N/A | -60.2% | 28.3% | N/A |
3 Yr | N/A* | -13.2% | 20.0% | N/A |
5 Yr | N/A* | -6.4% | 16.9% | N/A |
10 Yr | N/A* | 6.4% | 18.5% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | BOPACX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -79.9% | 24.2% | N/A |
2022 | N/A | -13.6% | 178.2% | N/A |
2021 | N/A | 3.8% | 63.8% | N/A |
2020 | N/A | -49.7% | 22.2% | N/A |
2019 | N/A | -59.8% | 54.4% | N/A |
NAV & Total Return History
BOPACX - Holdings
Concentration Analysis
BOPACX | Category Low | Category High | BOPACX % Rank | |
---|---|---|---|---|
Net Assets | N/A | 732 K | 46.2 B | N/A |
Number of Holdings | 35 | 21 | 473 | 84.69% |
Net Assets in Top 10 | 3.87 K | 2.18 K | 21.6 B | 98.09% |
Weighting of Top 10 | 38.76% | 12.3% | 80.8% | 79.43% |
Top 10 Holdings
- Intellia Therapeutics Inc 5.56%
- Moderna Inc 5.54%
- Biohaven Pharmaceutical Holding Co Ltd 4.28%
- BioNTech SE ADR 4.11%
- CRISPR Therapeutics AG 3.88%
- Dicerna Pharmaceuticals Inc 3.51%
- Repligen Corp 3.46%
- 10x Genomics Inc Ordinary Shares - Class A 3.25%
- Novavax Inc 3.21%
- Illumina Inc 3.10%
Asset Allocation
Weighting | Return Low | Return High | BOPACX % Rank | |
---|---|---|---|---|
Stocks | 100.01% | 85.37% | 106.13% | 2.87% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 89.95% |
Other | 0.00% | -22.99% | 3.38% | 89.95% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 89.95% |
Cash | 0.00% | -0.10% | 9.01% | 95.69% |
Bonds | 0.00% | 0.00% | 12.39% | 89.00% |
Stock Sector Breakdown
Weighting | Return Low | Return High | BOPACX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 44.98% |
Utilities | 0.00% | 0.00% | 0.00% | 89.00% |
Technology | 0.00% | 0.00% | 22.69% | 89.47% |
Real Estate | 0.00% | 0.00% | 7.13% | 89.00% |
Industrials | 0.00% | 0.00% | 7.02% | 89.00% |
Financial Services | 0.00% | 0.00% | 1.85% | 90.43% |
Energy | 0.00% | 0.00% | 0.00% | 89.00% |
Communication Services | 0.00% | 0.00% | 9.11% | 89.95% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 91.87% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 89.00% |
Basic Materials | 0.00% | 0.00% | 14.83% | 94.74% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | BOPACX % Rank | |
---|---|---|---|---|
US | 87.50% | 53.67% | 104.41% | 44.50% |
Non US | 12.51% | 0.00% | 45.40% | 47.37% |
BOPACX - Expenses
Operational Fees
BOPACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.39% | 0.08% | 3.13% | 81.60% |
Management Fee | N/A | 0.00% | 1.25% | N/A |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
BOPACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 0.00% | 0.00% | 5.75% | 87.76% |
Deferred Load | 1.25% | 1.00% | 5.00% | 54.35% |
Trading Fees
BOPACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
BOPACX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | N/A |
BOPACX - Distributions
Dividend Yield Analysis
BOPACX | Category Low | Category High | BOPACX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 8.63% | 87.38% |
Dividend Distribution Analysis
BOPACX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Monthly | Semi-Annually |
Net Income Ratio Analysis
BOPACX | Category Low | Category High | BOPACX % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | N/A |
Capital Gain Distribution Analysis
BOPACX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Semi-Annually | Annually |